A suspicious surge in trading of Schering-Plough Corp. sales just before news of its merger deal with fellow drugmaker Merck & Co. is being investigated by federal regulators, according to a published report.
The Securities and Exchange Commission is looking whether any trades were made by people with inside knowledge about the merger talks, unidentified people familiar with the situation told The Wall Street Journal on Thursday.
No comments:
Post a Comment